GENOMIC SOLUTIONS INC

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Certification of termination of registration of a class of securities (Section 12(g))

Additional Information for Proxy Statement/ Votes

Written communication about a business combination transaction (Rule 425)

General form for quarterly reports under Section 13 or 15(d)

4,7

Additional Information for Proxy Statement/ Votes

Written communication about a business combination transaction (Rule 425)

4,7

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Additional Information for Proxy Statement/ Votes

Written communication about a business combination transaction (Rule 425)

Additional Information for Proxy Statement/ Votes

Written communication about a business combination transaction (Rule 425)

5,7

Additional Information for Proxy Statement/ Votes

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

4,7

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Annual report pursuant to Section 13 or 15(d) (amendment)

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

2,7

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933

5,7

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

5,7

No description available

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

Post-effective amendment to a registration statement

Prospectus Supplement with Pricing Information

WICKER DAMION D MD

J P MORGAN PARTNERS SBIC LLC